New Cancer Treatment For Pancreatic, Stomach And Colon Cancer
Researchers found a way to develop new cancer treatments. The so called "collateral lethality" might be the answer to several types of cancer such as pancreatic, colon and stomach cancer. Collateral lethality is a therapeutic strategy uses passenger deleted genes as points of selective vulnerability.
Pancreatic, stomach and colon cancer are among the most common types of cancer. Colon cancer specifically is the third most common type of cancer which accounts to about 10 percent of cancer patients worldwide. Meanwhile, stomach cancer is the third most deadly type of cancer which makes up 7 percent of cancer cases and 9 percent of cancer deaths.
Typically, cancer cells deletes genes that suppress tumor formation. However, these deletions may also extend to neighboring genes with no direct role in the tumor progression in a process called collateral lethality. In a study published in Nature, on Wednesday, Jan. 18, scientists at The University of Texas MD Anderson Cancer discovered that this process can be used in novel therapy approaches for cancer.
"In an effort to expand therapeutic strategies beyond oncogenic targets to those not directly linked to cancer development, we have identified collateral lethal vulnerability in pancreatic cancers that can be targeted pharmacologically in certain patient populations," Prasenjit Dey, Ph.D., co-author of the study said, cited Science Daily. He added that genome data of several types of cancers reveal that this process might aid a new cancer treatment regime.
Doing a trial on mice, the researchers found out that when a common tumor suppressor in pancreatic cancer called SMAD4 is deleted during early cancer development, a nearby gene called malic enzyme 2 (ME2) is also eradicated. When the ME3 (sister gene to ME2) levels are depleted, it will lead to the regulation of branched chain amino acid (BCAA), which is important in cancer's ability to survive. This might be the key in preventing the growth of cancer tumors. The researchers added that more research is needed for the said cancer treatment.
Fasting Diet Miracle: 5-Day Calorie Restriction Lowers Risk For Major Diseases
Researchers are calling a healthy fasting diet a miracle due to its amazing capability of lowering major chronic diseases including cancer and diabetes. A specifically designed diet that mimics fasting could be the answer to all our health problems.
General Vaccine For Cancer Not Likely
The search for a general cure for cancer is still being done. A general vaccine for cancer is not yet likely.
Cancer Survival Rate May Increase With Hibernation
A novel approach to increase cancer survival rate involves deep freezing the patient's body to buy more time for doctors to formulate a good plan of care. Additionally, hibernation has the potential to stop tumors from growing.
The Power Of Cannabis Sheds Light In The Fight Against Brain Cancer
Considering that a lot of US’ states have been considering the legalization of cannabis and others have already been legalizing it, what’s the truth behind new claims that it can potentially be used as the secret weapon against brain cancer? Could it be the cure that can pave the way for other treatments involving cannabis? Find out what experts have to say about it
Cancer Treatment Might Become More Personalized
Cancer treatment so far has been elusive, but progress might be made soon. Cancer treatment might become more personalized.
Atomic Bomb Test Caused Cancers, New Mexico Alleges
The government in 1945 tested the first atomic bomb in southern New Mexico during World War I, now residents of Tularosa and four other New Mexico counties demand compensation from the government because health records show the atomic bomb test caused untold hardships and cancer-related illnesses down the generations of several families living near the test site area.
MORE IN ITECHPOST
Acer Aspire E 15 (E5-575-33BM) Is Amazon's Best-selling Laptop, Here's Why
Aspire E 15 (E5-575-33BM) packs in an Intel Core processor and a full HD screen for $350 which is purely a value for money.
'Tokyo Ghoul' Season 3 Delayed By Its Live-Action Movie? Ken Kenaki Returns With Another Identity?
"Tokyo Ghoul" season 3's release is delayed and there are countless speculations as to why it is being pushed back. Reports claim that the show is to give way to "One Punch Man" and "My Hero Acdemia" but new rumors say that it's lack of materials and storyline as well as its live-action movie are causing the delay.
Why Valve’s Revelation Of ‘Artifact’ Dismayed ‘Dota’ Fans?
The unexpected revelations of Valve's "Artifact" card game earned unexpected negative reactions from the Dota community.